Bukwang Pharm (003000) — Cash Flow-to-Debt Ratio
Bukwang Pharm (003000) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of ₩-6.24 Billion could theoretically repay 0% of its total liabilities (₩132.16 Billion) in one year. See 003000 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bukwang Pharm Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Bukwang Pharm across 13 annual periods. Also explore net asset momentum of Bukwang Pharm to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bukwang Pharm (2007–2024)
Year-by-year debt coverage analysis for Bukwang Pharm. For market capitalisation and broader financial context, see 003000 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | ₩34.36 Billion | ₩129.03 Billion | ▲ +654.0% |
| 2023 | -0.05x | ₩-9.36 Billion | ₩194.75 Billion | ▼ -137.7% |
| 2022 | 0.13x | ₩16.46 Billion | ₩129.08 Billion | ▼ -43.6% |
| 2021 | 0.23x | ₩26.52 Billion | ₩117.36 Billion | ▲ +3956.1% |
| 2020 | 0.01x | ₩723.17 Million | ₩129.78 Billion | ▲ +101.5% |
| 2019 | -0.38x | ₩-23.41 Billion | ₩62.05 Billion | ▼ -543.7% |
| 2018 | 0.09x | ₩6.82 Billion | ₩80.17 Billion | ▼ -75.2% |
| 2017 | 0.34x | ₩8.56 Billion | ₩24.93 Billion | ▲ +201.8% |
| 2016 | -0.34x | ₩-7.76 Billion | ₩23.00 Billion | ▼ -193.4% |
| 2015 | 0.36x | ₩10.30 Billion | ₩28.51 Billion | ▼ -65.2% |
| 2014 | 1.04x | ₩27.86 Billion | ₩26.82 Billion | ▼ -22.8% |
| 2013 | 1.35x | ₩36.52 Billion | ₩27.14 Billion | ▲ +114.3% |
| 2007 | 0.63x | ₩27.87 Billion | ₩44.39 Billion | — |